Search research articles
Contact Us
Filters
Showing results (61-70 of 100) with videos related to
Page
of 10
Sort By:
Neurobiology of Disease
|
December 3, 2022
Degenerate mapping of environmental location presages deficits in object-location encoding and memory in the 5xFAD mouse model for Alzheimer's disease
Hai Zhang, Lujia Chen, Kevin G Johnston, et al.
Nature Neuroscience
|
September 25, 2019
CA1-projecting subiculum neurons facilitate object-place learning
Yanjun Sun, Suoqin Jin, Xiaoxiao Lin, et al.
Journal of the National Cancer Institute
|
March 4, 2014
Response
Volker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Frontiers in Bioinformatics
|
November 20, 2025
Cellf-deception: human microglia clone 3 (HMC3) cells exhibit more astrocyte-like than microglia-like gene expression
Kylee K Rahm, Branden S Kinghorn, Myanna J Moody, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2008
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial
O Gluz, U A Nitz, N Harbeck, et al.
Journal of Alzheimer'S Disease : JAD
|
August 14, 2012
A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease
Elizabeth Head, Heather L Murphey, Amy L S Dowling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2026
Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer
Oleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
Clinical Proteomics
|
March 14, 2024
Human tear film protein sampling using soft contact lenses
Robert K Roden, Nathan Zuniga, Joshua C Wright, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 11, 2022
Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]
U A Nitz, O Gluz, M Christgen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel
U A Nitz, O Gluz, M Christgen, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 100) with videos related to
Sort By:
Page
of 10
Neurobiology of Disease
|
December 3, 2022
Degenerate mapping of environmental location presages deficits in object-location encoding and memory in the 5xFAD mouse model for Alzheimer's disease
Hai Zhang, Lujia Chen, Kevin G Johnston, et al.
Nature Neuroscience
|
September 25, 2019
CA1-projecting subiculum neurons facilitate object-place learning
Yanjun Sun, Suoqin Jin, Xiaoxiao Lin, et al.
Journal of the National Cancer Institute
|
March 4, 2014
Response
Volker Moebus, Christian Jackisch, Andreas Schneeweiss, et al.
Frontiers in Bioinformatics
|
November 20, 2025
Cellf-deception: human microglia clone 3 (HMC3) cells exhibit more astrocyte-like than microglia-like gene expression
Kylee K Rahm, Branden S Kinghorn, Myanna J Moody, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2008
Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial
O Gluz, U A Nitz, N Harbeck, et al.
Journal of Alzheimer'S Disease : JAD
|
August 14, 2012
A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease
Elizabeth Head, Heather L Murphey, Amy L S Dowling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2026
Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer
Oleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
Clinical Proteomics
|
March 14, 2024
Human tear film protein sampling using soft contact lenses
Robert K Roden, Nathan Zuniga, Joshua C Wright, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 11, 2022
Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]
U A Nitz, O Gluz, M Christgen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel
U A Nitz, O Gluz, M Christgen, et al.
Page
of 10